Friday, November 27, 2015

Injectable Biogel Delivers Anti-Cancer Agents To Tumors

Cancer Research

Smart Treatment: Paddock writes: “The aim of the smart biogel is to act as a cellular reservoir of immune cells that can be injected into tumors to eliminate the cancer.”
Photo Credit & Source: Medical News Today

An article, by Catharine Paddock, in Medical News Today says that researchers at the e University of Montreal Hospital Research Centre (CRCHUM) in Montreal, Quebec, have developed an injectable biogel that allows targeting of anti-cancer agents directly to the tumors.

In “‘Smart biogel’ that kills cancer tumors in development” (November 20, 2015), Paddock writes:
The researchers say the strength of their new biogel is that it is compatible with anti-cancer immune cells. It allows these cells or anti-cancer drugs to be injected directly into the cancer tumor instead of into the bloodstream. Coauthor Réjean Lapointe, an associate professor of medicine, says: “We hope that this targeted approach will improve current immunotherapies.”
Immunotherapy is a relatively new treatment method that enlists the immune system, or parts of it, to fight disease. One form of immunotherapy—called adoptive cell therapy - uses anti-cancer immune cells to treat cancer patients. The aim of adoptive cell therapy is to boost the presence of T lymphocytes, or T cells, in the body. These cells can kill cancer cells, but there are generally not enough of them to eradicate the cancer.
Thus, in adoptive cell therapy, extra T cells are grown in the lab from samples extracted from the patient and then re-injected back into their body to boost their own reserves. However, while the therapy has shown some promising results, it does not always produce enough T cells to kill the cancer completely. Also, it has to be administered with high doses of the hormone interleukin-2, which can be toxic.
Such is the current thinking and approach of cancer research and its therapies, most notably immunotherapy, which focuses on aiding the human body's T-cells to attack cancer. Chemotherapies are still being used as a way to treat cancer; immunotherapy will have to be proven as least as good as this long-standing traditional method before it becomes the method of choice. When this happens, it will be a breakthrough. Chemotherapy, although effective, results in a list of side effects, many unpleasant.

The article, “Chitosan thermogels for local expansion and delivery of tumor-specific T lymphocytes towards enhanced cancer immunotherapies,” is published in Biomaterials: Volume 75, January 2016, Pages 237–249.

For more, go to [MedNewsToday

No comments:

Post a Comment

All comments ought to reflect the post in question. All comments are moderated; and inappropriate comments, including those that attack persons, those that use profanity and those that are hateful, will not be tolerated. So, keep it on target, clean and thoughtful. This is not a forum for personal vendettas or to create a toxic environment. The chief idea is to engage, to discuss and to critique issues. Doing so within acceptable norms will make the process more rewarding and healthy for everyone. Accordingly, anonymous comments will not be posted.